THE Formulation and Characterization of Transdermal Patch of Candesartan Celexitil
The aim of the present study is to formulate and characterized the transdermal patch of Candesartan celexitil. The objective is study was to increase the bioavailability of drug. In the present study, transdermal patch of Candesartan celexitil were prepared by solvent casting technique employing HPMC cps 50 polymer and glycerin as plasticizer using mercury as substrate. Total thirteen formulation (F1-F13) were prepared having drug and polymer ratio (1:2, 1:4, 1:6, 1:8, and 1:10). From the selected batch F2 containing drug polymer ratio (1:4), four formulations each were prepared and evaluated containg drug urea (1-4%) and oleic acid (1-4%) as permeation enhancer. The prepared transdermal patches were evaluated on the basis of different parameters like weigh, thickness, folding endurance, percent moisture absorption, percent moisture loss, drug content uniformity, in vitro skin permeation study. The fabricated final transdermal patches were further subjected to in vitro permeation study. In order to confirm the exact mechanism of drug release from all the patches, the data were computed and graphed according to Korsmeyer equation. Diffusion exponent of release process controlled by Super case Ⅱ transport Non- Fickian diffusion, n values of Korsmeyer- Peppas model shows a combination of diffusion and dissolution mechanism indicating the drug release from the formulation was controlled by more than one process. It was concluded that the prepared formulation F13 (4% w/v of oleic acid) showed highest cumulative percent drug release and increase the bioavailability of the drug.
Keywords: Novel drug delivery system, Transdermal drug delivery, Transdermal drug delivery system, Differential scanning calorimetry.
2. Hardainiyan S, Nandy BC, Jasuja ND, Vyas P, Raghav PK. A Review; on the recent innovation in transdermal drug delivery for Herbal therapy. J. of Bio. And Pharm. Res. 2014; 3(3):88-101.
3. Ahmed A, Karki N, Charde R, Charde M , Ganghare B. Transdermal drug delivery system an Overview. Int. J. Biomed. Adv. Res. 2011; 38-56.
4. Patel A, Visht S, Sharma PK. Transdermal Drug Delivery system, Next Generation Patches . J. Drug discov. Del. 1:43-65.
5. Tripathi KD. Essentail of medical pharmacology. 7th ed., New Delhi. Jaypee Publisher Ltd. 2008:639.
6. Allen LV. Dosage form design and development. Clinical Therapy. 2008; 30(11):2102-2111.
7. Samanta MK, Dube R, Suresh B. Transdermal drug delivery system of haloperidol to overcome self induced extrapyramidal syndrome. Drug Dev. Ind. Pharm. 2003; 29:405-415.
8. Leeson PD, Springthore B. The influence of drug- like concepts on decision-making in medical chemistry. Nature Rev. Drug Discov. 2007; 6:881-890.
9. James EF Reynolds. Martindle the extra pharmacopoeia. 28th ed. London: The Pharmaceutical Press; 1982.
10. Longanathan V, Senthilkumar B, Reddy MVS, Sreekanth N, Ubaidulla U. Compatibility studies between oflaxacin tablet excipinet through differential scanning calorimetry. Int. J. Pharm. Excip.2003; 2(3,4):661-64.
11. Kalvimoorthi V, Rajeshkaran M, Rajan VS, Balasubramani KP, Kumar PS. Transdermal drug delivery system: An over review. Int. J. Pharm. Chem. Sci. 2015; 4(1):89-101.
12. Samanta MK, Dube R, Suresh B. Transdermal drug delivery system of haloperidol to overcome self induced extrapyramidal syndrome. Drug Dev. Ind. Pharm. 2003; 29:405-415.
13. Jamakandi VG, Mulla JS, Vinay BL, Shivakumara HN. Formulation characterization and evaluation of matrix - type transdermal patch of model antihypertensive drug. Asian J. Pharm. 2009; 3(1):59-64.
14. Raghavendra K, Ali M, Doddayya H, Dr. Marshal SC, Patil CC, Habbu PV. Comparitive evaluation of polymeric films for transdermal application. The Eastern Pharmacist 2000; XLIII (516):109-111.
15. Patel NB, Sonapal RN, Mohan S, Selvaraj S. Formulation and evaluation of Intophoretic transdermal delivery of Diltiazam Hydrochloride. Int. J. Res. Pharm. Sci. 2010; 1(3):338-344.
16. Kusam DV, Saisivam S, Maria GR, Deepti PU. Design and evaluation of matrix diffusion controlled transdermal patches of verapamil hydrochloride. Drug Dev. Ind. Pharm. 2003; 29(5):495-503.
17. Flynn GL, Durrhein H, Huguchi WI. Permeation through hairless mouse skin II: membrane sectioning techniques and influence on alkanols permeabilities. J. Pharm. Sci. 2003; 70(1):52-56.
18. Singh S, Bakshi M. Guidence on the conduct of stress tests to determine the inherent stability of drugs. Pharm. Tech. 2000; 1-14.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeÂ The Effect of Open Access).